Archives
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.
AIG Chairman Steve Miller to step down in July: WSJ
American International Group Inc (AIG.N) Chairman Robert "Steve" Miller intends to step down in July after five years in the role, the Wall Street Journal reported.
Ackman says shutting Herbalife down is key to him
Hedge fund mogul William Ackman, who has spent more than two years accusing Herbalife Ltd (HLF.N) of running a pyramid scheme, said on Monday that shutting down the company is "one of the most important things" he can do.
Wall St. rebounds from recent losses; deals help
U.S. stocks climbed more than 1 percent on Monday, rebounding from a sharp decline last week, helped by deal activity in healthcare and a bounce in energy shares.